Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

NICE: New Proportionate Approach To HTAs ‘Flexible, But Not Bespoke’

Nov 09 2023

• By Eliza Slawther

Jenniffer Prescott speaking at the NICE annual conference 2023

Related Content

England’s Unused Innovative Medicines Fund Under Fire Again

Aug 25 2023

England’s NICE Formalizes Faster Approach To Appraisals

Nov 03 2023

NICE Pilots Show New Streamlined Approaches To Accelerated Health Technology Assessments

May 03 2023

UK Reveals Seven Partners Whose New Drug Approvals It Will Recognize

May 26 2023

NICE Braces For HTA-Related Challenges Posed By UK’s International Recognition Procedure

Oct 23 2023

Additional Topics

Cost Effectiveness Health Technology Assessment Innovation Market Access Policy Regulation Reimbursement Review Pathway BioPharmaceutical

More from Market Access

More from Pink Sheet

Twitter feed RSS feed RSS feed

About Us

Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us

Customer Service
SubscribeOpens in new window
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window

Copyright © 2025 Pharma Intelligence UK Limited (Citeline), a Norstella company Pharma Intelligence UK Limited is a company registered in England and Wales with company number 13787459 whose registered.